Whether these effects are connected to a possible pro-inflammatory role of the CaSR in the intestine is still under debate and necessitates clarification, in particular in light of the possible detrimental effects that a calcimimetic-based therapy could exert in patients suffering from colitis. Here, CASR is linked to colitis.